You are here

Article info

Article menu
Download PDFPDF
Archimedes
Question 1: Palivizumab for all children with Down syndrome?

Authors

  • Dean Huggard Discipline of Paediatrics, Trinity College, University of Dublin, Dublin, Ireland PubMed articlesGoogle scholar articles
  • Eleanor J Molloy Discipline of Paediatrics, Trinity College, University of Dublin, Dublin, Ireland Neonatology, Our Lady’s Children’s Hospital, Dublin, Ireland Paediatrics, Tallaght Hospital, Dublin, Ireland Neonatology, Coombe Women & Infants University Hospital, Dublin, Ireland PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Dean Huggard, Department of Paediatrics, Trinity Centre for Health Sciences, Tallaght Hospital, Dublin 24, Ireland; dean.huggard{at}gmail.com
View Full Text

Citation

Huggard D, Molloy EJ
Question 1: Palivizumab for all children with Down syndrome?
Archives of Disease in Childhood 2019;104:94-97.

Publication history

  • Received August 30, 2018
  • Revised September 10, 2018
  • Accepted September 14, 2018
  • First published October 2, 2018.
Online issue publication 
December 13, 2018

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.